Results 141 to 150 of about 18,115 (178)

KRAS G12C inhibitors in KRAS^G12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis. [PDF]

Front Immunol
Yan Y, Zheng L, Wang H, Sun L, Xu X.
europepmc   +1 more source

Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study. [PDF]

Gut Liver
Cho Y, Lee JH, Ryoo BY, Lim HY, Lee DE, Kim BH, Park JW.   +6 more
europepmc   +1 more source

Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysis. [PDF]

Oncologist
Pfeiffer P, Cremolini C, Ducreux M, Osterlund P, Ronnebaum S, Akin-Fajiye M, Paly V, Hernandez L, Elez E.   +8 more
europepmc   +1 more source

Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma. [PDF]

Cancer Manag Res
Wang D, Zhang W, Gao X, Kong H, Zhang H, Huang J, Zhang M, Chang X, Zeng Z.   +8 more
europepmc   +1 more source

Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma. [PDF]

Curr Oncol Rep
Wysocki PT, Chmiel P, Jassem J, Kraj L.
europepmc   +1 more source

Prognostic Impact of the Systemic Immune-Inflammation Index in Unresectable Hepatocellular Carcinoma Undergoing Second-Line Combination Therapy: A Multicenter Study. [PDF]

Cancer Manag Res
Chen X, Li X, Jiang Y, Xie Q, Zhang P, Zhou X, Wei C, Xie P, Cao L.   +8 more
europepmc   +1 more source

Phospho-JNK agonists show promising effects for the treatment of hepatocellular carcinoma. [PDF]

iScience
Kim W, Jin H, Miao P, Ozcan M, Liao X, Li M, Iqbal S, Sebhaoui J, Ashraf S, Belmen B, Turkez H, Boren J, Uhlen M, Shi X, Zhang C, Mardinoglu A.   +15 more
europepmc   +1 more source

Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer. [PDF]

Life (Basel)
Cheng MC, Chen PH, Chen YG, Lai SW, Chen JH, Dai MS, Chang PY.   +6 more
europepmc   +1 more source

Repositioned donafenib versus standard regorafenib for second-line HCC treatment: A matched cohort study. [PDF]

Medicine (Baltimore)
Chen X, Li X, Li X, Jiang Y, Xie Q, Xie P, Cao L.   +6 more
europepmc   +1 more source

Safe management of sequential chemotherapy in a hemodialysis patient with metastatic colorectal cancer: A case report. [PDF]

Oncol Lett
Sasaki R, Hara N, Kojitani Y, Yoshii Y, Ota M, Okazaki S, Takeda M.   +6 more
europepmc   +1 more source